Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polive is a biotechnology company focused on the development of innovative therapeutic solutions, particularly in the field of rare diseases and lysosomal storage disorders. The company leverages its expertise in small molecule drug discovery to address significant unmet medical needs. Polive's research and development efforts are centered on identifying and optimizing novel chemical entities with the potential to modify disease progression. By focusing on specific metabolic pathways, the company aims to provide effective treatments for patients with limited options. Polive is committed to advancing its pipeline through rigorous pre-clinical testing and strategic collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polive.